Madison Avenue Partners, LP
In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 14, 2024), Madison Avenue Partners, LP reported 20 stock positions worth $791.6 million. Its top holding was Graham Class B (GHC) at 20.6% of the portfolio, followed by Solventum (SOLV, 16.5%) and Globus Medical Class A (GMED, 12.3%). Compared with Q1 2024, it opened 6 new positions, sold out of 4, added to 8 and reduced 3. The biggest buy was a new position in Solventum (SOLV) and the biggest sale Sharkninja (SN, shares −60%).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001801265
- Portfolio Value
- $791.6M (Q2 2024)
- SEC Filing
- 0001801265-24-000009 ↗ filed Aug 14, 2024
Holdings Value
Holdings 20 stocks · $791.6M
| GHC Graham Holdings Co. Class B | 20.63% | 233,484 | $163.3M | Add +10.8% |
| SOLV Solventum Corp. | 16.47% | 2,464,934 | $130.3M | New |
| GMED Globus Medical Inc. Class A | 12.25% | 1,416,168 | $97.0M | Add +101.4% |
| TBPH Theravance Biopharma Inc. | 9.12% | 8,511,350 | $72.2M | Add +21.4% |
| WLY Wiley (john) & Sons Class A | 8.38% | 1,630,517 | $66.4M | Add +19.3% |
| SN Sharkninja Inc. | 6.85% | 721,578 | $54.2M | Reduce -60.1% |
| QDEL Quidelortho Corp. | 6.28% | 1,497,148 | $49.7M | New |
| STGW Stagwell Inc. | 6.16% | 7,147,662 | $48.7M | No change |
| NNI Nelnet Inc. Class A | 3.70% | 290,213 | $29.3M | No change |
| DCO Ducommun Inc. | 2.81% | 382,495 | $22.2M | New |
| ATMU Atmus Filtration Technologie | 1.51% | 415,366 | $12.0M | Add +441.3% |
| NWSA News Corp. Class A | 1.49% | 428,040 | $11.8M | New |
| TSVT 2SEVENTY Bio Inc. | 1.25% | 2,563,222 | $9.9M | Add +5.3% |
| FSP Franklin Street Properties C | 0.64% | 3,291,443 | $5.0M | No change |
| ZIMV Zimvie Inc. | 0.62% | 270,927 | $4.9M | New |
| INDV Indivior Ltd. | 0.46% | 223,432 | $3.6M | Add +37.2% |
| CEE Central and Eastern Europe F | 0.45% | 337,046 | $3.6M | Reduce -20.3% |
| OVID Ovid Therapeutics Inc. | 0.40% | 4,082,100 | $3.1M | Add +11.9% |
| MCHB Mechanics Bancorp Class A filed as HOMESTREET INC | 0.35% | 240,903 | $2.7M | Reduce -73.4% |
| NWS News Corp. Class B | 0.19% | 52,534 | $1.5M | New |
Portfolio Sells Q1 2024 → Q2 2024
| SN Sharkninja Inc. | Reduce -60.1% | 6.85% | −11.31 |
| HES Hess Corp. | Sold out | 0.00% | −7.39 |
| MCHB Mechanics Bancorp Class A | Reduce -73.4% | 0.35% | −1.85 |
| ONL Orion Properties Inc. | Sold out | 0.00% | −1.48 |
| MACK Merrimack Pharmaceuticals Inc. | Sold out | 0.00% | −0.92 |
| GOSS Gossamer Bio Inc. | Sold out | 0.00% | −0.79 |
| CEE Central and Eastern Europe F | Reduce -20.3% | 0.45% | −0.20 |
Portfolio Buys Q1 2024 → Q2 2024
| SOLV Solventum Corp. | New | 16.47% | +16.47 |
| QDEL Quidelortho Corp. | New | 6.28% | +6.28 |
| GMED Globus Medical Inc. Class A | Add +101.4% | 12.25% | +6.17 |
| DCO Ducommun Inc. | New | 2.81% | +2.81 |
| NWSA News Corp. Class A | New | 1.49% | +1.49 |
| ATMU Atmus Filtration Technologie | Add +441.3% | 1.51% | +1.11 |
| ZIMV Zimvie Inc. | New | 0.62% | +0.62 |
| NWS News Corp. Class B | New | 0.19% | +0.19 |
| WLY Wiley (john) & Sons Class A | Add +19.3% | 8.38% | −0.02 |
| INDV Indivior Ltd. | Add +37.2% | 0.46% | −0.11 |
| TSVT 2SEVENTY Bio Inc. | Add +5.3% | 1.25% | −0.85 |
| TBPH Theravance Biopharma Inc. | Add +21.4% | 9.12% | −1.03 |
| OVID Ovid Therapeutics Inc. | Add +11.9% | 0.40% | −1.40 |
| GHC Graham Holdings Co. Class B | Add +10.8% | 20.63% | −5.46 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 25 | $2.3B | GHC, INVH, MKL, CPNG, MICC |
| Q1 2026 | 27 | $2.3B | SNDK, GHC, CPNG, MICC, MKL |
| Q4 2025 | 23 | $2.3B | SNDK, GHC, GMED, INDV, MKL |
| Q3 2025 | 20 | $1.7B | GHC, SNDK, MKL, INDV, GMED |
| Q2 2025 | 26 | $1.5B | GHC, SOLV, MKL, SNDK, INDV |
| Q1 2025 | 22 | $1.2B | GHC, SOLV, MKL, WLY, TBPH |
| Q4 2024 | 15 | $944.4M | GHC, SOLV, WLY, TBPH, ACHC |
| Q3 2024 | 25 | $1.1B | SOLV, GHC, LBRDK, WLY, GMED |
| Q2 2024 | 20 | $791.6M | GHC, SOLV, GMED, TBPH, WLY |
| Q1 2024 | 18 | $619.9M | GHC, SN, TBPH, WLY, HES |